Location History:
- Texas Township, MI (US) (1995)
- Kalamazoo, MI (US) (1994 - 2003)
Company Filing History:
4 out of 523 
2 out of 2,170 
1 out of 1,858 
Years Active: 1994-2003
Title: Jerry R Colca: Innovator in Insulin Sensitizing Agents
Introduction
Jerry R Colca is a notable inventor based in Kalamazoo, MI (US). He has made significant contributions to the field of medicine, particularly in the treatment of hypertension in insulin-resistant patients. With a total of 7 patents to his name, Colca's work has had a meaningful impact on healthcare.
Latest Patents
One of Jerry R Colca's latest patents is titled "Method and use - Use of insulin sensitizing agents to treat hypertension." This invention provides a method for treating hypertension in insulin-resistant patients through the administration of insulin sensitizing agents, specifically ciglitazone or pioglitazone. This innovative approach aims to improve the quality of life for individuals suffering from both hypertension and insulin resistance.
Career Highlights
Throughout his career, Colca has worked with prominent companies such as Pharmacia & Upjohn Company and The Upjohn Company. His experience in these organizations has allowed him to develop and refine his inventions, contributing to advancements in medical treatments.
Collaborations
Jerry R Colca has collaborated with notable individuals in his field, including Takashi Sohda and Hitoshi Ikeda. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work.
Conclusion
In summary, Jerry R Colca is a distinguished inventor whose work in insulin sensitizing agents has the potential to transform the treatment of hypertension in insulin-resistant patients. His contributions to the field are invaluable and continue to influence medical practices today.